Merck Biopharma Korea released the results of a real-world evidence (RWE) study of Mavenclad (cladribine) for multiple sclerosis (MS) in Korean patients at the 40th European Committee for Treatment...
While there is no cure for multiple sclerosis (MS), there are several types of drug treatments that can reduce the number and intensity of relapses and slow the progression of the disease. ; Additionally, a variety of rehabilitative therapies can help people maintain their mobility and independence and manage their MS symptoms. ; Many people with MS also try one or more complementary therapies to address symptoms, relieve stress, and improve quality of life.
Tysabri is a drug used to treat multiple sclerosis (MS). WebMD explains how it works.
FDA approves Mayzent (cladribine), a new oral drug to treat multiple sclerosis
Though there’s no cure for multiple sclerosis, treatment can help slow its progression and reduce symptoms. Learn about these treatments and more.
primary-progressive multiple sclerosis. It is the first FDA-approved treatment for the primary progressive form. When the FDA approved the drug, it required Roche to conduct several Phase...
Available therapies and treatments for multiple sclerosis (MS) reduce inflammation, delay the progression of the disease, reduce the frequency and severity of acute attacks, and improve walking.
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-...
WebMD explains the symptoms and treatment of relapsing-remitting multiple sclerosis, the most common of the four types of MS.
Affiliation 1 Department of Neurology, University of Rochester School of Medicine and Dentistry, New York.